Hot
Human IL-4 R alpha / CD124 Protein, His Tag, low endotoxin (MALS & SPR verified)Cat. No. ILR-H5221
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Oturkibart | HDM3016; QX-005N; HDM-3016 | Phase 3 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Chronic Urticaria; Dermatitis, Atopic; Nasal Polyps; Prurigo; Pulmonary Disease, Chronic Obstructive; Sinusitis | Details |
| Dupilumab biosimilar (Jingxing Pharmaceutical) | GS101; GS-101; GS-101 (Jingxing Pharmaceutical) | Phase 3 Clinical | Jiangsu Jingxing Pharmaceutical Technology Co Ltd | Dermatitis, Atopic | Details |
| Dupilumab biosimilar (Qilu Pharma) | QL2108; QL-2108 | Phase 3 Clinical | Qilu Pharmaceutical Co Ltd | Asthma; Dermatitis, Atopic; Prurigo | Details |
| siLR4A | siLR4A | Phase 3 Clinical | National Skin Centre, Singapore | Keloid; Wounds and Injuries | Details |
| TQH2722 | TQC2722; TQC-2722; TQH 2722; TQH-2722; TQH2722; BSI-045A | Phase 3 Clinical | Biosion Inc, Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Dermatitis, Atopic; Inflammation; Nasal Polyps; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Sinusitis | Details |
| SHR-1819 | SHR-1819 | Phase 3 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Asthma; Chronic Urticaria; Dermatitis, Atopic; Nasal Polyps; Prurigo; Prurigo Nodularis; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Sinusitis | Details |
| JNJ-5939 | JNJ-5939; NM-26; NM26-2198; JNJ-95475939 | Phase 2 Clinical | Numab Therapeutics Ag | Dermatitis, Atopic; Inflammation | Details |
| AK-139 | AK139; AK-139 | Phase 2 Clinical | Kangfang Biotechnology (Cayman) Co Ltd | Asthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Hypersensitivity; Prurigo Nodularis; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal | Details |
| IBI-3002 | IBI3002; IBI-3002 | Phase 2 Clinical | Asthma; Dermatitis, Atopic | Details | |
| SHR-4597 | SHR-4597; SHR4597 | Phase 2 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Asthma | Details |
| RC-1416 | RC14/16; RC-1416 | Phase 2 Clinical | Nanjing RegeneCore Biotech Co Ltd | Asthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive | Details |
| BA-2101 | BA-2101; BA2101; PR-103; PR103 | Phase 2 Clinical | Shandong Boan Biotechnology Co Ltd | Asthma; Chronic Urticaria; Dermatitis, Atopic; Nasal Polyps; Prurigo; Pruritus; Pulmonary Disease, Chronic Obstructive; Sinusitis; Urticaria | Details |
| Sorafenib Tosylate/Comekibart | MG-D-1609 | Phase 2 Clinical | Metagone Biotech Inc | Solid tumours | Details |
| LQ-036 | LQ-036 | Phase 2 Clinical | Shanghai Novamab Biopharmaceuticals Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| Dupixent biosimilar (Chong Kun Dang Pharmaceutical) | CKD-706 | Phase 1 Clinical | Chong Kun Dang Pharmaceutical Corp | Dermatitis, Atopic | Details |
| Dupilumab biosimilar (China Resources Biopharma) | Phase 1 Clinical | China Resources Biopharmaceutical Co Ltd | Dermatitis, Atopic | Details | |
| Dupilumab biosimilar (Jiangsu Jingxing Pharma) | Phase 1 Clinical | Jiangsu Jingxing Pharmaceutical Technology Co Ltd | Dermatitis, Atopic | Details | |
| Dupilumab biosimilar (Chengdu Kanghong) | KH-816; KH816 | Phase 1 Clinical | Chengdu Kanghong Biotechnologies Co Ltd | Dermatitis, Atopic | Details |
| BR-2060 | BR-2060; BR2060 | Phase 1 Clinical | Zhejiang BioRay Biopharmaceuticals Co Ltd | Autoimmune Diseases; Dermatitis, Atopic | Details |
| Dupilumab biosimilar (Jushi Biopharma) | Phase 1 Clinical | Jushi Biopharmaceutical Co Ltd | Dermatitis, Atopic | Details | |
| BBT-001 | BBT001; BBT-001 | Phase 1 Clinical | Bambusa Therapeutics Inc | Dermatitis, Atopic | Details |
| Dupilumab biosimilar (Bio-Thera Solutions) | BAT2406; BAT-2406 | Phase 1 Clinical | Bio-Thera Solutions Ltd | Asthma; Dermatitis, Atopic; Eosinophilic Esophagitis; Nasal Polyps; Prurigo Nodularis; Sinusitis | Details |
| APG-808 | APG808; PR-001; PR001; APG-808 | Phase 1 Clinical | Apogee Therapeutics Inc, Paragon Therapeutics Inc | Pulmonary Disease, Chronic Obstructive | Details |
| HY-1770 | HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770 | Phase 1 Clinical | Suzhou Pharmavan Co Ltd | Dermatitis, Atopic; Plaque psoriasis | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Stapokibart | CM-310 | Approved | Keymed Biosciences Co Ltd | 康悦达, Kangyueda | Mainland China | Dermatitis, Atopic | Chengdu Kangnuoxing Biopharma Inc | 2024-09-10 | Asthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Conjunctivitis, Allergic; Dermatitis, Atopic; Nasal Polyps; Pemphigoid, Bullous; Prurigo; Prurigo Nodularis; Pruritus; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Sinusitis; Solid tumours | Details |
| Dupilumab | REGN-668; SAR-231893 | Approved | Regeneron Pharmaceuticals Inc, Sanofi | Dupixent, 达必妥 | United States | Dermatitis, Atopic | Regeneron Pharmaceuticals Inc | 2017-03-28 | Allergic Fungal Rhinosinusitis; Alopecia Areata; Angioedema; Aspergillosis, Allergic Bronchopulmonary; Asthma; Asthma, Aspirin-Induced; Chronic Urticaria; Colitis, Ulcerative; Conjunctivitis, Allergic; Coronavirus Disease 2019 (COVID-19); Dermatitis; Dermatitis, Atopic; Eczema; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Genetic Diseases, Inborn; Hypereosinophilic Syndrome; Hypersensitivity; Hypersensitivity, Immediate; Keloid; Keratoconjunctivitis; Lichenoid Eruptions; Milk Hypersensitivity; Nasal Polyps; Nephrotic Syndrome; Neurodermatitis; Paranasal Sinus Diseases; Peanut Hypersensitivity; Pemphigoid, Bullous; Prostatic Neoplasms; Prurigo; Prurigo Nodularis; Pruritus; Pulmonary Disease, Chronic Obstructive; Respiration Disorders; Respiratory Sounds; Respiratory Tract Diseases; Rhinitis, Allergic; Scleroderma, Localized; Sinusitis; Skin Diseases; Skin Diseases, Eczematous; Sleep Apnea Syndromes; Urticaria | Details |
